Sudarshan Sukhani of s2analytics.com recommends buying Ajanta Pharma, Dabur India and PVR.
Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Individual stocks keep on offering opportunities. I have opportunities mainly on the buy side which is where the market is, it is only 50 points lower than its all-time highs."
"Consider buying Ajanta Pharma. Pharmaceuticals are doing rather well today; it is not just Ajanta Pharma, other stocks are also having upside momentum. However, today’s selection is Ajanta Pharma."
"Dabur India from the FMCG pack is also a buy. Try to keep these day trading buys because we have a three day extended weekend, so we might us well take it easy."
"The third in my list is also a buy, PVR. The stock has gone through a bear market of its own and that bear market is now ending. So not only is it a day trade, it is also something that positional traders willing to hold positions can consider.""So Ajanta Pharma, Dabur, and PVR, all for buying," he added.